PureTech Health is to develop a combination of a microbiome treatment with checkpoint inhibitor immunotherapy to enhance the effect of the cancer drugs.
Roche has signed a deal with Warp Drive Bio to discover and develop new antibiotics, badly needed to combat the growing threat of multi-drug resistant bacteria.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
